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Crystal Structure of the Catalytic
Domain of the Human Cell Cycle Control
Phosphatase, Cdc25A
The human genome encodes at least three Cdc25
enzymes, identified as A, B, and C (Galaktionov and
Beach, 1991), which appear to have specificity for differ-
ent Cdk/cyclin complexes. Cdc25C dephosphorylates
Cdk2/cyclin B, which in turn phosphorylates and acti-
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vates Cdc25C, creating a positive feedback loop regu-1Biophysics Research Division
lating entry into M phase (Hoffmann et al., 1993). Cdc25Aand the Department of Biological Chemistry
is expressed during the G1→S transition and is pre-The University of Michigan
sumed to promote entry into S phase by acting on Cdk2/Ann Arbor, Michigan 48109-1055
cyclin A and Cdk2/cyclin E (Hoffmann et al., 1994; Jinno2Department of Functional Genetics
et al., 1994). Cdc25A is a substrate for Cdk2/cyclin E,3Department of Structural Chemistry
suggesting the involvement of another positive feed-4Department of Molecular Sciences
back loop at this stage of the cell cycle.Glaxo Wellcome, Inc.
A variety of protein tyrosine and dual-specificity (tyro-Research Triangle Park, North Carolina 27709
sine and serine/threonine) phosphatases have been5Howard Hughes Medical Institute
identified (Fauman and Saper, 1996). All employ a similarDepartment of Cell Biology and Physiology
two-step hydrolysis reaction proceeding through a phos-Washington University School of Medicine
phocysteine intermediate, unlike the serine/threonineSt. Louis, Missouri 63110
phosphatases, which use a one-step, metal-dependent
hydration. The vaccinia virus H1 phosphatase (VH1) was
the first phosphatase reported to display dual specificitySummary
(Guan et al., 1991). The structure of VHR, a human homo-
log of VH1, is very similar to the structure of the tyrosine-Cdc25 phosphatases activate the cell division kinases
specific phosphatases (e.g., Yersinia enterocolitica YopH,throughout the cell cycle. The 2.3 AÊ structure of the
human PTP1B, and PTPa), and there are conserved resi-human Cdc25A catalytic domain reveals a small a/b
dues throughout their sequences (Figure 1) (Yuvaniyamadomain with a fold unlike previously described phos-
et al., 1996). As deduced from these four crystal struc-phatase structures but identical to rhodanese, a sul-
tures, the phosphate moiety of the substrate is cradledfur-transfer protein. Only the active-site loop, con-
in an active-site loop formed by the residues of the con-taining the Cys-(X)5-Arg motif, shows similarity to the served His-Cys-(X)5-Arg sequence. A conserved aspar-tyrosine phosphatases. In some crystals, the catalytic
tic acid from an adjacent loop facilitates catalysis byCys-430 forms a disulfide bond with the invariant Cys-
protonating the leaving group. The low molecular weight384, suggesting that Cdc25 may be self-inhibited dur-
phosphatases, while distinct in sequence and structure,ing oxidative stress. Asp-383, previously proposed to
also possess an active-site Cys-(X)5-Arg sequence andbe the general acid, instead serves a structural role,
catalytic aspartic acid (Su et al., 1994; Zhang et al.,forming a conserved buried salt-bridge. We propose
1994a).that Glu-431 may act as a general acid. Structure-
Aside from the sequence His-Cys-(X)5-Arg, Cdc25 hasbased alignments suggest that the noncatalytic do-
no sequence homology with thecatalytic domains of the
main of the MAP kinase phosphatases will share this
other protein tyrosine or dual-specificity phosphatases
topology, as will ACR2, a eukaryotic arsenical resis-
(Strausfeld et al., 1991). Two earlier, and widely cited,
tance protein. reports suggested more extensive sequence similarity
between Schizosaccharomyces pombe Cdc25 and VH1
Introduction
(Gautier et al., 1991; Moreno and Nurse, 1991). However,
as additional sequences for Cdc25s and VH1-like dual-
The cyclin-dependent serine/threonine protein kinases specificity enzymes have become available, it has be-
(Cdks) ensure an orderly progression through the eukary- come apparent that Cdc25 is a distinct family. Of the
otic cell cycle (Morgan, 1995; Fisher, 1997). They are 19 residues found in common between the two original
positively regulated through association with cyclin pro- proteins, only the 3 from His-Cys-(X)5-Arg are conserved
teins and phosphorylation at a conserved threonine, in both families.
Thr-161. They are kept inactive until needed by phos- Despite limited sequence similarity, indications are
phorylation at position Tyr-15 in yeast or both Tyr-15 that Cdc25 uses the same catalytic mechanism as the
and Thr-14 in higher eukaryotes (Gould and Nurse, 1989; other protein tyrosine and dual-specificity phosphatases.
Krek and Nigg, 1991). Final activation of the kinase de- Mutation of either the cysteine or the arginine of the
pends on the dual-specificity phosphatase Cdc25, which Cys-(X)5-Arg motif inactivates the enzyme (Gautier et al.,
dephosphorylates both Tyr-15 and Thr-14 (Strausfeld et 1991). Further, Cdc25 exhibits a two-step mechanism
al., 1991; Honda et al., 1993). (Gottlin et al., 1996), presumably proceeding through a
phosphocysteine intermediate, as seen in the other Cys-
(X)5-Arg phosphatases (Guan and Dixon, 1991).6 To whom correspondence should be addressed.
VHR and VH1 share sequence similarities with the7 Present address: Roche Bioscience, Molecular Structure Depart-
ment, Palo Alto, California 94304-1397. catalytic domains of the MAP kinase phosphatases
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Figure 1. Domain Organization of Proteins
Structurally and Functionally Related to Cdc25
Domains for MKP and ACR2 are defined from
sequence comparisons alone; the rest all in-
clude results of crystal structure determina-
tions. Gray, rounded rectangle represents the
prototypical protein tyrosine phosphatase
domain. White rectangle represents a Cdc25-
like domain, including CH2A (green oval) and
CH2B (blue oval) motifs. Small, red rectangle
indicates position of a Cys-(X)5-Arg motif or,
in the case of rhodanese, the isolated cata-
lytic cysteine.
(MKPs), such as PAC1 and CL100 (Figure 1). Surpris- Burke, 1996). This abbreviated construct binds Cdk2/
cyclin A as well as the full-length Cdc25B.ingly, tworegions of homology (termed CH2A and CH2B)
were identified between sequences in the N-terminal, To elucidate the relationship between the Cdc25s and
the other protein tyrosine phosphatases, the functionsnoncatalytic domain of the MKPs and sequences flank-
ing the active site of Cdc25 (Figure 1) (Keyse and Gins- of the CH2 domains, and the substrate-specificity deter-
minants of Cdc25, we determined the crystal structureburg, 1993).
The human Cdc25s are 470±530 residues in length of the catalytic domain of human Cdc25A.
and arecomposed of two domains: a variable N-terminal
region, suspected to serve regulatory functions (Peng Results and Discussion
et al., 1997), and a highly conserved C-terminal catalytic
domain, containing the CH2A, Cys-(X)5-Arg, and CH2B The Overall Structure
We determined the X-ray crystal structure of the cata-motifs. Deletion experiments localized the catalytic ac-
tivity to the last 175 residues of human Cdc25B (Xu and lytic domain of human Cdc25A (residues 336±523) by
Figure 2. Ribbon Drawing of the Catalytic
Domain of Human Cdc25A
The CH2A, active site, and CH2B motifs are
indicated in green, red, and blue, respec-
tively. The side chain of the Cys-430 nucleo-
phile is shown in yellow. The N terminus (resi-
due 335) is indicated on the left (N), while the
C terminus extends toward the viewer and
is clipped in this figure. Figure created with
MOLSCRIPT (Kraulis, 1991) and the ray-trac-
ing program VORT (University of Melbourne).
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Figure 3. Topological Comparison of Cdc25
and Related Proteins
Depicted are (A) Cdc25A, (B) rhodanese (PDB
entry 2ORA;Gliubich et al., 1996), (C) the VH1-
like dual specificity phosphatase, VHR (PDB
entry 1VHR; Yuvaniyama et al., 1996), and (D)
the bovine low molecular weight phospha-
tase (PDB entry 1PNT; Zhang et al., 1994a).
While all the proteins have an a/b fold con-
sisting of a b sheet surrounded by a helices,
only Cdc25 and rhodanese are topologically
equivalent. The CH2A, active site, and CH2B
motifs are indicated in green, red, and blue,
respectively. Helices are shown as circles;
strands, as triangles. N and C indicate the
N and C termini of each domain. Red ªCysº
indicates position of the nucleophilic cyste-
ine, while ªAspº indicates the general acid
in VHR and the bovine low molecular weight
phosphatase. Ribbon drawings created with
MOLSCRIPT (Kraulis, 1991).
the multiple isomorphous replacement method (Table that of both halves of the sulfur transfer protein, rho-
danese (Figures 3 and 4). Rhodanese is highly conserved1) and refined the model to a crystallographic R-factor
of 22.7% at a resolution of 2.3 AÊ . and is found in bacteria and mitochondria, although
the exact biological role is still unknown. Rhodanese isThe topology of the catalytic domain is unlike that of
any other phosphatase (Figures 2 and 3). Cdc25A is a composed of two domains of identical topology, but
low sequence similarity, believed to be the result of asmall a/b domain with a central five-stranded parallel b
sheet in the order 15423. Three helices lie below the gene duplication (Ploegman et al., 1978). Only the sec-
ond domain contains the active site with a nucleophilicsheet (as viewed in Figure 2), and two longer helices lie
over the sheet. The dual-specificity phosphatases and cysteine. We previously noted that rhodanese shared
with the Yersinia phosphatase an unusual loop confor-the core of the tyrosine-specific phosphatases are also
a/b structures of similar size but possess a mixed, five- mation that directs eight sequential main chain nitro-
gens in toward an anion-binding site (Stuckey et al.,stranded b sheet in the order 12534. The low molecular
weight phosphatases have a four-stranded parallel b 1994), a structure which has now been seen in all protein
tyrosine phosphatases. However, while the analogy be-sheet in the order 2134.
Surprisingly, the topology of Cdc25A is identical to tween rhodanese and the other tyrosine phosphatases
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encompasses only the active-site strand-loop-helix re-
gion, the similarity between Cdc25A and each half of
rhodanese includes all the secondary structures.
A comparison with a database of representative pro-
tein folds (Holm and Sander, 1994) confirmed that rho-
danese is the only other known structure to share
Cdc25A's topology, with a Z score of 10.3 (standard
deviations above the mean), a root-mean-square devia-
tion (rmsd) of 2.8 AÊ over 109 a carbon positions and
12 sequence identities. Eighteen unrelated a/b proteins
have Z scores of between 3.5 and 2.3. The Yersinia
phosphatase and VHR each receive Z scores no higher
than 2.3 (rmsd more than 4.3 AÊ over about 80 a carbons,
8 or fewer sequence identities). For comparison, the
Yersinia phosphatase and VHR structures share a Z
score of 12.9, with an rmsd of 3.1 AÊ over 160 a carbons
and 25 identities, and the two halves of rhodanese score
13.6 with an rmsd of 2.1 AÊ over 119 a carbons and 15
identities.
While the low molecular weight phosphatase structure
is even more dissimilar (Z score 5 1.9), it can be made
more similar through a simple circular permutation. The
Cys-(X)5-Arg motif in the low molecular weight phospha-
tase occurs near the N terminus (Figure 3D). A hypotheti-
cal structure, in which the N and C termini of the low
molecular phosphatase are fused and new termini are
introduced between the second strand and helix, re-
ceives a Z score of 5.5 (rmsd 2.9 over 94 a carbons,
14 sequence identities) when compared to the Cdc25A
structure. Although this circular permutation aligns the
active-site Cys-(X)5-Arg motifs, it is doubtful that this
cryptic topological similarity implies any evolutionary
relationship, since more extensive sequence similarities
are absent.
The Active Site
In common with the other Cys-(X)5-Arg phosphatases,
the Cys-(X)5-Arg motif in Cdc25A lies on a loop between
a b strand and a helix (red, in Figures 2, 3, and 4). The
catalytic cysteine, Cys-430, is the last residue of the
strand and projects into the center of the loop (Figure
5). The Glu-431 side chain points above the loop. Phe-
432 and Glu-435 point away from the loop, while Ser-
433 and Ser-434 point into the loop. The Og of Ser-433
is within hydrogen bonding distance of the Sg of Cys-
430. In this position, it could stabilize the thiolate ion of
Cys-430, assisting in the second step of catalysis in a
manner analogous to Thr-410 of the Yersinia phospha-
tase or Ser-131 of VHR (Denu and Dixon, 1995). Arg-
436 sits far above the loop and does not appear to be
well positioned to assist in catalysis. The side chain of
His-429 forms a hydrogen bond with the carbonyl of
Cys-430, supporting the strained main chain dihedral
angles for that residue.
In contrast to the other Cys-(X)5-Arg phosphatases,
the active site of Cdc25 is extremely shallow (Figure 5).
There are no auxiliary loops, which extend over the ac-
tive site, as there are, for example, in the Yersinia phos-
phatase or VHR. The active-site Phe-432 may help to
recognize tyrosine substrates, analogous to Tyr-128 of
VHR or the conserved Phe-229 of the Yersinia phospha-
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tase. Recognition of the Cdk substrate probably relies
Crystal Structure of Human Cdc25A
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Figure 4. Sequence Alignment Comparing Cdc25 to Rhodanese, MAP Kinase Phosphatase, and Two S. cerevisiae Genes, ACR2 and YG4E
Sequences listed for Cdc25, Rhod1, Rhod2, and MKP are consensus sequences constructed by taking all available sequences with at least
25% sequence identity with Cdc25A, bovine rhodanese domain 1, bovine rhodanese domain 2, or CL100, respectively. Capital letters indicate
highly conserved positions in each consensus sequence. Light shading indicates regions of structural equivalence between Cdc25A and both
rhodanese domains, as determined by the LSQ_IMPROVE routine of O (Jones et al., 1991). Dark shading indicates sequence similarities
between highly conserved positions. Secondary structure elements are indicated above the sequences (arrows, b strands; rounded rectangles,
a helices). Sequence numbers are for Cdc25A. The CH2A, active site, and CH2B motifs are indicated in green, red, and blue, respectively.
on an extensive protein±protein interface, as opposed may explain Cdc25's sensitivity to oxidation and loss
of activity in the absence of reducing agents, whichto a few select residues right at the active site. There
is one report that Cdc25 hydrolyzes Thr-14 more readily hampered its early identification as a phosphatase (Dun-
phy and Kumagai, 1991; Kumagai and Dunphy, 1991).than Tyr-15 (Borgne and Meijer, 1996). We believe this
is primarily due to the greater accessibility of Thr-14 as Whether the potential to form this disulfide reflects a
physiological mechanism for enzyme inhibition duringrevealed in the crystal structure of Cdk2/cyclin A (Russo
et al., 1996). oxidative stress in vivo is not known. However, it was
recently reported that natural killer cells subjected toThe catalytic Cys-430 can form a disulfide bridge with
the absolutely conserved Cys-384 on the adjacent b thiol deprivation show Cdk hyperphosphorylation and
cell cycle arrest, presumably due to inhibition of Cdc25strand (Figures 5 and 6). In the refined native structure,
the two thiol groups are 5.9 AÊ apart, and there is no (Yamauchi and Bloom, 1997).
evidence for a disulfide. However, in some crystals, in-
cluding one grown in the presence of 3 mM sodium The CH2A Motif
The first 23 residues of the catalytic domain (residuesvanadate, difference electron density consistent with a
disulfide is clearly visible (Figure 6B). This observation 335±357) meander with no regular secondary structure.
Figure 5. The Active Site of Cdc25A
(A) Ball-and-stick model.
(B) CPK model, in the same orientation, with
a molecular surface (Nicholls et al., 1991) in
gold. Unlabeled residues are gray; all others
are colored according to chemical property.
The C-terminal tail of Cdc25A can be seen
behind the active site, extending away from
the protein. Graphics rendered with O (Jones
et al., 1991) and VORT (University of Mel-
bourne).
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al., 1996), assisting in catalysis by donating a proton to
the leaving group hydroxyl, by analogy to the Yersinia
phosphatase reaction (Zhang et al., 1994b). Replace-
ment of Asp-383 with Asn reduced kcat by at least 150-
fold; however, the analogous experiment in the Yersinia
phosphatase reduces kcat/kM by 1000-fold. In the crystal
structure, Asp-383 points away from the active site and
cannot be considered to participate in catalysis (Figure
7). The rate reduction observed likely owes to the disrup-
tion of the salt bridge with the buried Arg-385, which is
also absolutely conserved. That Asp-383 is also con-
served in the CH2A motifs of domains with no phospha-
tase activity (Figure 4) further supports the notion that
this residue is conserved for structural, rather than
mechanistic, reasons.
The only acidic residue close enough to the active
site to serve as a general acid is the absolutely con-
served Glu-431, immediately following the nucleophilic
cysteine (Figure 5). This residue has never been inde-
pendently mutated. However, Gautier and colleagues
observed that replacing the five residues following the
active-site cysteine (Glu-Phe-Ser-Ser-Glu) with the se-
quence (Ser-Ala-Gly-Val-Gly) resulted in complete loss
of activity (Gautier et al., 1991). There is, however, no
requirement that Cdc25 contain a general acid. For ex-
ample, the maximum turnover rate for the Yersinia phos-
phatase with the general acid removed is 0.9 s21 against
pNPP (Zhang et al., 1994b), compared to 0.35 s21 for
the intact catalytic domain of Cdc25B (Gottlin et al.,Figure 6. Electron Density Maps Showing Formation of a Disulfide
1996).Bond between Absolutely Conserved Cysteines
(A) In the native refined model, there isno positive difference electron
density. (B) However, when oxidized, Cys-384 appears to form a The CH2B Motifdisulfide with Cys-430. Calculated structure factors for a 2Fo±Fc map
The CH2B motif (residues 459±488; blue in Figures 2, 3,(0.8 s, black) and an Fo±Fc map (3.0 s, blue) are from the native
and 4) consists of a strand followed by a helix, whichmodel, which is shown with carbon, nitrogen, oxygen, and sulfur
atoms in yellow, blue, red, and green, respectively. Observed ampli- is situated under the active-site loop such that its
tudes are from either (A) the native crystal or (B) a crystal grown in N-terminal end points towards the active site (Figure 2).
the presence of 3 mM vanadate. However, no bound vanadate was A final short strand forms the second half of a b ribbon
located in the electron density maps from this crystal. Graphics
with the CH2A motif. Many of the highly conserved resi-were rendered with O (Jones et al., 1991) and VORT (University of
dues contribute to a small hydrophobic core within theMelbourne).
CH2B motif (Tyr-469, Phe-473, Cys-480, Tyr-485). The
absolutely conserved Pro-482 contains a cis-peptideThe initial Leu-Ile-Gly-Asp sequence, characteristic of
bond.the start of the Cdc25 catalytic domain (Eckstein et al.,
The Cdc25 sequences show less similarity in the re-1996), forms a short loop extending away from the pro-
gion following the CH2B motif (Figure 4). In the crystaltein, presumably leading to the N-terminal domain of
structure, residues 489±496 form an extended structureCdc25. After the irregular region, a short strand, helix,
projecting away from the rest of the protein, interactingand loop extend behind the b sheet, leading into the
with neighboring proteins in the crystal lattice. ResiduesCH2A motif. Conserved residues in this region (Ile-359,
497±523 are disordered and are not visible in the elec-Met-364, Val-367, Leu-368) contribute to the protein's
tron density maps, although there is room for the addi-hydrophobic cores.
tional 27 residues in the crystal lattice. The penultimateThe CH2A motif (residues 379±401; green in Figures
highly conserved residue of Cdc25, Met-488, packs be-3, 4, and 5) is the first of two regions identified because
tween the conserved Tyr-386 and Tyr-388 of the CH2Aof significant sequence identity with the noncatalytic
motif (Figures 5 and 7). In human Cdc25C, the last 38domain of the MKPs. CH2A is largely a self-contained
residues, up to this methionine, can be removed withoutstrand-helix-strand domain, with many of thehighly con-
affecting pNPP or Cdc2 hydrolase activity (Lee et al.,served residues (Asp-383, Arg-385, Tyr-390, His-394,
1992).Asn-400) forming hydrogen bonds to side chain and
main chain atoms within the subdomain (Figure 7). Be-
tween the helix and the second strand is another short A Recurring Fold
The structures of Cdc25A and rhodanese identify a con-strand (residues 394±396), which forms a small anti-
parallel b ribbon with a segment of the CH2B motif. stellation of approximately 24 residues that together
determine the topology of this 140-residue domain (Fig-The absolutely conserved Asp-383 had been pro-
posed to be a general acid in the reaction (Eckstein et ure 4). These 24 residues also include nearly all of the
Crystal Structure of Human Cdc25A
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Figure 7. Conserved Residues in the CH2A
Region in Cdc25A
Asp-383, Arg-385, Tyr-390, His-394, and Asn-
400 all make intradomain hydrogen bonds.
The small side chain of Ala-398 makes room
for Tyr-390. Tyr-386, Pro-387, Tyr-388, and
Glu-389, which point away from the CH2A
motif, are conserved in all Cdc25s but not in
rhodanese and MKPs. Figure generated with
Molscript (Kraulis, 1991) and VORT (Univer-
sity of Melbourne).
sequence identities seen between Cdc25s from different in the N-terminal lobe of Cdc2, the MKPs dephosphory-
late residues in the larger, C-terminal lobe of MAP ki-species, between Cdc25 and the N-terminal region of
nases. Perhaps the N-terminal domain of the MKPs con-the MKPs, between rhodaneses from different sources,
fers binding between MKP and the N-terminal lobe ofand between the twohalves of rhodanese. Many of these
the MAP kinases.residues lie within the CH2A and CH2B regions, motifs
Residues that are highly conserved among the Cdc25swhich were defined originally based solely on identities
but not conserved in the other sequences (Figure 4) arebetween Cdc25 and the MKPs. Remarkably, the rho-
likely to be serving functional instead of structural roles.danese PROSITE (Bairoch et al., 1997) motifs, which
One example is the sequence Tyr-Pro-Tyr-Glu (residuesdistill the salient features of rhodanese sequences, also
386±389), which projects out from the CH2A helix (Figurelie within the CH2A and CH2B regions, even though
7). These residues may be involved in specific interac-these PROSITE motifs were constructed with reference
tions between Cdc25 and its Cdk substrate.to rhodanese sequences alone.
The sequence and structural similarity between Cdc25
and rhodanese suggests they be classed together as Conclusion
proteins of identical topology containing an active-site Much of the literature for the past six years has relied
nucleophilic cysteine. Other proteins that show the on an assumption of homology between Cdc25 and the
same constellation of conserved amino acids probably other known dual-specificity and tyrosine-specific phos-
also possess this same topology. One example would phatases (e.g., Eckstein et al., 1996). The structure of
be ACR2, a unique eukaryotic arsenate resistance en- the catalytic domain of Cdc25A, compared to those of
zyme in Saccharomyces cerevisiae (Bobrowicz et al., the other Cys-(X)5-Arg phosphatases, suggests other-
1997; Wysocki et al., 1997), which contains a Cys-(X)5- wise. The Yersinia phosphatase (Stuckey et al., 1994),
Arg motif (Figures 1 and 4). By analogy with the bacterial PTP1B (Barford et al., 1994), PTPa (Bilwes et al., 1996),
ArsC protein (Gladysheva et al., 1996) and based on the and VHR (Yuvaniyama et al., 1996) all share a common
structure of Cdc25, we propose that ACR2 uses its Cys- topology and possess sequence similarity in regions
76 as a nucleophile to reduce arsenate to arsenite. An- away from the active site. Cdc25 has its own topology
other S. cerevisiae protein, YG4E, is 27% identical in and groups of highly conserved residues and most likely
sequence to ACR2, including the Cys-(X)5-Argmotif (Fig- represents the results of convergent evolution toward
ure 4). YG4E has no known function but also likely the Cys-(X)5-Arg solution of phosphomonoester hydroly-
adopts the Cdc25 fold. sis. In this light, the low molecular weight phosphatases
Basedon the pattern of conservedresidues, the MKPs may be seen as yet a third case of convergent evolution
probably also have this same topology in their N-termi- toward this solution (Ramponi and Stefani, 1997).
nal, noncatalytic domains, even though the Cys-(X)5-Arg
motif is absent there (Figures 1 and 4). These sequence
Experimental Proceduressimilarities may reflect similar biological targets. The sub-
strates of Cdc25 and the MKPs are Cdk2 and the MAP Sample Preparation
kinases, homologous serine/threonine kinases (Gold- Human Cdc25A cDNA was obtained from David Beach (Cold Spring
Harbor Laboratory). DNA encoding amino acids 336-523, plus ansmith and Cobb, 1994). But while Cdc25 acts onresidues
Cell
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initiating methionine, was amplified by PCR, confirmed by sequenc- Byrnes and Mary Stephenson for preliminary recombinant protein
preparations. This work was supported in part by the National Insti-ing, and cloned into a pET21a vector (Novagen). Cdc25A (336-523)
was overexpressed in Escherichia coli BL21 (DE3) cells and purified tutes of Health grants (AI34095 to M. A. S. and GM47017 to H. P.-W.)
and a grant from the John and Suzanne Munn Endowed Researchto homogeneity in a three-column procedure on a Pharmacia BioPi-
lot system at 48C. Cation exchange (Poros HS 50-micron media) Fund of the University of Michigan Comprehensive Cancer Center.
H. P.-W. is an investigator of the Howard Hughes Medical Institute.followed by a concentration step over the same media and then a
size exclusion column (Pharmacia S-75 Superdex) generated about
0.5 g of pure protein per 10 l of E. coli. Seleno-L-methionine±labeled
Received March 10, 1998; revised April 13, 1998.protein was similarly purified from E. coli B834 (DE3) cells, grown
in 23 M9 medium supplemented with 0.1 g/l ampicillin, 2.0 g/l glu-
cose, 246 mg/l Mg2SO4±7H2O, 11 mg/l CaCl2, 33.7 mg/l thiamine-
ReferencesHCl, 30 mg/l cysteine, and 30 mg/l seleno-L-methionine (Sigma). A
glutathione-S-transferase fusion protein of the full-length enzyme,
Bairoch, A., Bucher, P., and Hofmann, K. (1997). The PROSITE data-Cdc25A (1-523) was purified from E. coli BL21 (DE3) by binding and
base, its status in 1997. Nucleic Acids Res. 25, 217±221.elution from Glutathione Sepharose 4B. Purified Cdc25A (336-523)
appears to be 16-fold more active than GST-Cdc25A (1-523) in de- Barford, D., Flint, A.J., and Tonks, N.K. (1994). Crystal structure of
phosphorylating Cdk2 labeled by the protein kinase Wee1 (data not human protein tyrosine phosphatase 1B. Science 263, 1397±1404.
shown). Bilwes, A.M., den Hertog, J., Hunter, T., and Noel, J.P. (1996). Struc-
tural basis for inhibition of receptor protein-tyrosine phosphatase
Crystallization alpha by dimerization. Nature 382, 555±559.
Crystals of Cdc25A (336-523) and of the seleno-L-methionine±
Bobrowicz, P., Wysocki, R., Owsianik, G., Goffeau, A., and Ulaszew-containing protein were grown in hanging drops by the vapor diffu-
ski, S. (1997). Isolation of three contiguous genes, ACR1, ACR2 andsion method at 48C. Four microliters of protein (10 mg/ml in 200 mM
ACR3, involved in resistance to arsenic compounds in the yeastNaCl, 1 mM DTT, 20 mM HEPES [pH 7.4]) plus 4 ml of precipitant
Saccharomyces cerevisiae. Yeast 13, 819±828.(18%±20% PEG 3350 [Hampton], 0.025% b-octylglucoside, 0.11 M
Borgne, A., and Meijer, L. (1996). Sequential dephosphorylation ofsodium citrate [pH 5.8]) were equilibrated against 1 ml of precipitant.
p34(cdc2) on Thr-14 and Tyr-15 at the prophase/metaphase transi-Large (1.0 3 0.2 3 0.2 mm3) square pyramidal crystals appeared in
tion. J. Biol. Chem. 271, 27847±27854.2±3 days. Drops that did not spontaneously nucleate were seeded
with microcrystals diluted in precipitant. BruÈ nger, A.T. (1992). Slow-cooling protocols for crystallographic
refinement by simulated annealing. Acta Cryst. A46, 585±593.
Data Collection Collaborative Computational Project, No. 4 (1994). The CCP4 suite:
Prior to data collection, cryosolvent (25% PEG 400, 75% precipitant programs for protein crystallography. Acta Cryst. D50, 760±763.
solution) was slowly added to the hanging drop. For heavy atom
Cowtan, K. (1994). ªdmº: an automated procedure for phase im-derivatives, crystals were next soaked in cryosolvent containing 10
provement by density modification. Joint CCP4 and ESF-EACBMmM of the desired heavy atom solution for 24±48 hr. Crystals were
Newsletter on Protein Crystallography 31, 34±38.flash frozen and maintained at 120 K with nitrogen gas cooled by
Denu, J.M., and Dixon, J.E. (1995). A catalytic mechanism for thethe X-stream (Molecular Structure Corporation) system. Diffraction
dual-specific phosphatases. Proc. Natl. Acad. Sci. USA 92, 5910±intensities for the native crystal and most of the derivatives were
5914.collected on an R-AXIS IV/Rigaku RU-200 system running at 50 kV
100 mA; intensities for the thimersol derivatives were collected on Dunphy, W.G., and Kumagai, A. (1991). The cdc25 protein contains
an R-AXIS II. Intensities were integrated, scaled, and merged with an intrinsic phosphatase activity. Cell 67, 189±196.
DENZO (Otwinowski and Minor, 1997) and were converted to ampli- Eckstein, J.W., Beer-Romero, P.B., and Berdo, I. (1996). Identifica-
tudes by the method of French and Wilson (1978). Crystals were of tion of an essential acidic residue in Cdc25 protein phosphatase
the space group P41 (or P43), with a 5 b 5 43.5 AÊ , c 5 117.1 AÊ . and a general three-dimensional model for a core region in protein
phosphatases. Protein Sci. 5, 5±12.
Phasing and Refinement
Fauman, E.B., and Saper, M.A. (1996). Structure and function of theSites for the p-chloromercuriphenol derivative were found by Pat-
protein tyrosine phosphatases. Trends Biochem. Sci. 21, 413±417.terson techniques. Sites for the remaining derivatives were located
Fisher, R.P. (1997). CDKs and cyclins in transition(s). Curr. Opin.in difference Fourier maps and confirmed in Patterson Harker sec-
Cell Biol. Genet. 7, 32±38.tions. Heavy atom sites were refined and phases calculated to 2.2
AÊ with MLPHARE (Collaborative Computational Project No. 4, 1994), French, G.S., and Wilson, K.S. (1978). On the treatment of negative
giving an overall figure of merit of 0.64. The initial trace into solvent- intensity observations. Acta Cryst. A34, 517±525.
flattened 3.0 AÊ maps (Cowtan, 1994) located all major secondary Galaktionov, K., and Beach, D. (1991). Specific activation of cdc25
structures and identified P41 as the correct enantiomorph. Assign- tyrosine phosphatase by B-type cyclins: evidence for multiple roles
ment of sequence and connectivity was aided by positions of sele- of mitotic cyclins. Cell 67, 1181±1194.
nium peaks in methionine side chains and a relatively accurate
Gautier, J., Solomon, M.J., Boojer, R.N., Bazan, J.F., and Kirschner,secondary structure prediction (Rost and Sander, 1994). The final
M.W. (1991). cdc25 is a specific tyrosine phosphatase that directlymodel, after cycles of fitting (Jones et al., 1991) and refinement
activates p34cdc2. Cell 67, 197±211.(BruÈ nger, 1992), contains 162 residues and 69 water molecules. The
Gladysheva, T., Liu, J., and Rosen, B.P. (1996). His-8 lowers the pKafirst residue in the structure is Met-335, which was introduced during
of the essential Cys-12 residue of the ArsC arsenate reductase ofcloning. The C terminus is disordered, and residues Leu-497 through
Leu-523 cannot be located. The final model, including individual plasmid R773. J. Biol. Chem. 271, 33256±33260.
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